MedPeer

MedPeer ROE

Delisted

The Return on Equity (ROE) of MedPeer (6095.T) as of Oct 8, 2026 is 15.68 %. In the previous year, Return on Equity (ROE) was 7.45 % — a change of 110.56% (higher).

ROE

15.68 %

YoY

110.56%

Last updated:

In 2024, MedPeer's return on equity (ROE) was 15.68 %, a 110.56% increase from the 7.45 % ROE in the previous year.

The MedPeer ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2017
-44.01 JPY
Jan 1, 2018
12.51 JPY
Jan 1, 2019
12.11 JPY
Jan 1, 2020
13.56 JPY
Jan 1, 2021
19.28 JPY
Jan 1, 2022
10.70 JPY
Jan 1, 2023
7.45 JPY
Jan 1, 2024
15.68 JPY
The MedPeer ROE history
YEARROEYoY
15.68 %+110.56%
7.45 %-30.41%
10.70 %-44.51%
19.28 %+42.18%
13.56 %+12.03%
12.11 %-3.23%
12.51 %-128.42%
-44.01 %-2,376.95%
1.93 %-68.56%
6.15 %-56.86%
14.25 %—
Access this data via the Eulerpool API

MedPeer Stock analysis

What does MedPeer do? MedPeer Inc is a US-American company that was founded in Boston, Massachusetts in 2004. The company develops and operates social networks and platforms for doctors and medical students. The business model of MedPeer is focused on bringing doctors and medical students together on a platform where they can exchange medical information, ask and answer questions, and engage in discussions on current medical topics. MedPeer is primarily a platform that provides information and support to medical professionals and facilitates the exchange of valuable information. MedPeer also offers various specialized sections that provide specific information and support to doctors and medical students. These sections include, among others, gastroenterology, cardiology, oncology, neurology, dermatology, and mental health. In the field of gastroenterology, MedPeer provides information on the diagnosis and treatment of gastrointestinal diseases. In the field of cardiology, MedPeer provides information on the diagnosis and treatment of cardiovascular diseases. In the field of oncology, MedPeer provides information on cancer treatment. In the field of neurology, MedPeer provides information on the treatment of neurological diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. In the field of dermatology, MedPeer provides information on the diagnosis and treatment of skin diseases. In the field of mental health, MedPeer provides information on the diagnosis and treatment of mental illnesses such as depression and anxiety. MedPeer also offers products that are designed to assist doctors and medical students in their work and studies. An example of this is the MedPeer Academy course, which prepares medical students for their clinical rotations and prepares them for the exam they must take at the end of their rotation period. Other products offered by MedPeer include digital medical libraries that provide access to thousands of medical articles, journals, and textbooks. Additionally, MedPeer offers various software tools designed to assist doctors in the diagnosis and treatment of patients. Over the years, MedPeer has received several awards and recognitions, including first place in the "Medical Services and Equipment" category at the Global Mobile Awards 2014. Furthermore, the company has received a significant amount of venture capital investments in recent years. The company has also recently entered into a partnership with Allm, a Japanese provider of mobile and web applications for the healthcare sector. The partnership aims to allow MedPeer to enter the Japanese market and expand its services and products to a larger audience. Overall, MedPeer has made significant progress in recent years and has become a key player in the medical information and communication industry. The company has demonstrated its ability to provide high-quality products and services that can assist doctors and medical students in their work and studies. MedPeer is one of the most popular companies on Eulerpool.

ROE Details

Decoding MedPeer's Return on Equity (ROE)

MedPeer's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing MedPeer's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

MedPeer's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in MedPeer’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about MedPeer stock

Return on Equity (ROE) of MedPeer is 15.68 % in 2024.

Return on Equity (ROE) of MedPeer changed from 7.45 % to 15.68 %, representing a 110.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) MedPeer since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s MedPeer with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — MedPeer

All Key Metrics — MedPeer